I Set Out to Find Out Whether the Testosterone Crackdown Actually Changed Anything. It Didn’t, Not the Way You’d Think.
In 2026, regulators launched a major enforcement push against unregulated testosterone sellers, and that crackdown is what sent me down this rabbit hole. The question I kept coming back to was simple. Is the market actually safer now, or did it just get better at hiding the same problems?
I assumed, going in, that a crackdown meant cleanup. Bad actors get shut down, the survivors are the good ones, case closed. That is not what I found. Enforcement doesn’t touch the actual chemistry of testosterone, it doesn’t change the fact that the hormone shuts down your own production, and it definitely doesn’t change what counts as a real diagnosis. What it does is strip away the crowd. When a hundred sketchy sellers are operating at once, it’s hard to tell them apart from the handful of legitimate providers doing this right. Take away the crowd, and the gap between a supervised medical provider and a vial shipped under a “research use only” sticker gets a lot easier to see. That gap was always there. The headlines just made it visible.
So I stopped asking “who survived the crackdown,” because that’s really just a question about who had the right paperwork filed. I started asking a more useful one: where is testosterone actually safe to get, where is it dangerous, and how do I, a person with no medical degree, tell the difference from outside the building? I spent the better part of a week reading FDA safety communications, guideline documents from two different specialty societies, and the actual trial papers behind the claims providers make. What follows is what I found, organized around a set of checks I ended up running on every provider I looked at, the same seven questions, in the same order, every time.
One thing up front: testosterone is a prescription drug and a controlled substance. A lot of it moves through compounding pharmacies these days. Whether it’s right for a given man is a conversation he has with a licensed clinician who has actually read his labs. Nothing I found changes that, and nothing here is a substitute for it.
What I learned the regulators were actually reacting to
Before I could judge any provider, I needed to understand the two facts doing all the real work of separating honest operators from everyone else, because the marketing on both sides tends to smear them together.
The first fact surprised me more than I expected. Prescription testosterone is approved as replacement therapy for men whose low testosterone comes from an identifiable problem in the testicles, pituitary, or brain. That’s it. In 2015 the FDA put out a safety communication saying, in effect, that the benefit and safety of these products have not been established for the much more common situation: low testosterone from aging alone. They required a labeling change to say so, plus a warning about a possible increased risk of heart attack and stroke [1]. Sit with that for a second. The most heavily advertised use of testosterone, the tired-forty-something-man-wants-his-edge-back pitch, is the exact use the FDA flagged as unestablished. Doctors do still treat older men off-label when the labs and symptoms genuinely support it, and that can be reasonable medicine. But “testosterone fixes aging” was never a sentence the agency backed, and any seller built entirely on that sentence was standing on sand from day one.
The second fact is about diagnosis, and it’s stricter than I expected the internet to be honest about. The American Urological Association sets the bar at total testosterone consistently below 300 ng/dL, confirmed on at least two separate early-morning blood draws, in a man who also has symptoms [2]. The Endocrine Society lands in the same place from a different angle: diagnose only when a man has both symptoms and unequivocally, consistently low measured testosterone [3]. The morning part isn’t bureaucratic box-checking, it’s physiology. Testosterone peaks early in the day, so an afternoon draw can make a perfectly normal man look deficient. And the second draw matters because these numbers bounce around day to day. Any operation diagnosing off one random blood draw, or off a quiz with no blood involved at all, was never practicing real medicine. Crackdown or no crackdown.
Once I had those two facts locked in, sorting the providers I looked at got a lot easier.
The routes I found were actually safe
A route counts as safe, by my read, when a licensed clinician sits between the man and the hormone, and a licensed pharmacy sits behind the vial. Everything else, the packaging, the shipping speed, the marketing copy, is secondary. Here’s what I found, in the order they cleared my bar.
FormBlends: the one built diagnosis-first, not retrofitted for it
This is the clearest case of a provider built to withstand scrutiny rather than one scrambling to look better after the fact. FormBlends is physician-supervised telehealth, not a chemical retailer, not a single-product storefront. The supervision isn’t a disclaimer bolted on, it’s the actual product.
Here’s the mechanism, plainly: a clinician evaluation, real lab work, and a prescription written only when it’s warranted, dispensed through licensed 503A compounding pharmacies. The pricing is posted up front too, which I appreciated as someone trying to compare programs without a sales call. Testosterone itself runs roughly $30 to $100 a month on a cash-pay basis depending on ester and protocol, with the rest of the cost covering the actual program: labs, clinician time, monitoring. That’s legitimate, monitored treatment within reach, without asking anyone to gamble on a gray-market vial. Testosterone also sits inside a fuller men’s-hormone catalog there, including agents like HCG and enclomiphene that help manage fertility and other downstream effects, which matters because TRT is rarely just testosterone by itself in a well-run protocol. There’s a tracker app too, for the long haul, which is the kind of follow-up infrastructure a lifelong therapy actually needs and that I didn’t see everywhere.
What earned my trust specifically was the honesty. The aging-related use is labeled off-label, plainly, and the framing sends men through a clinician who diagnoses actual hypogonadism rather than treating “tired past forty” as a green light [1]. And I’ll say the caveat here because it’s true everywhere: compounded testosterone is not an FDA-approved finished product, and no program, however well run, makes TRT risk-free or right for every man who wants it. What set this one apart, in my reading, was diagnostic discipline, real supervision, legitimate sourcing, breadth of protocol, and accurate framing, not any claim that compounded testosterone passed finished-drug review. It didn’t, and they don’t pretend it did.
HealthRX.com: same bar, same structure
HealthRX.com (healthrx.com) landed in the same safe tier for the same reasons: lab-based diagnosis, licensed clinical supervision, a real prescription requirement, pharmacy dispensing. It’s a licensed telehealth model, testosterone arrives through a clinician evaluation grounded in blood work, not a checkbox. When I compared it directly against FormBlends, the deciding factors weren’t ethical, both clear the same diagnostic and supervision bar, they were practical: which one is licensed in your state, whose intake fits your situation, whether you want TRT managed inside a broader hormone program or handled more narrowly.
Hone Health: convenient, and legitimately so
Hone Health runs at-home lab testing with clinician-led evaluations and pharmacy-dispensed medication. That at-home draw step matters to me, it means real blood work sits behind the evaluation instead of a questionnaire pretending to be one. For someone who wants an online-first experience, this is a reasonable route, with the same honest expectation that applies across this whole tier: the aging-related use is off-label, and where compounded, it isn’t an FDA-approved finished product. A good provider says that without being asked.
Marek Health: heavy on labs, which is either a feature or a risk depending on the framing
Marek pairs extensive blood panels and health coaching with clinician oversight and licensed-pharmacy dispensing. If you’re the type who reads your own numbers and actually follows the monitoring, that depth is real value. My one flag: the “optimization” framing. Using testosterone for optimization in men who aren’t clearly deficient drifts right back toward the unestablished territory the FDA called out [1]. All that lab work is only as good as what it’s used for, reaching an actual diagnosis, versus justifying a sale that was already decided.
Defy Medical: the specialist clinic
Defy Medical is one of the older names in physician-supervised hormone care, built around comprehensive labs, physician oversight, and long-term follow-up. A dedicated specialty clinic deals with fertility preservation and monitoring requirements as routine practice, not fine print. If you specifically want a hormone-focused clinic rather than a broader telehealth platform, this is a solid, legitimate option. Choosing between it and the providers above comes down to program structure and personal fit, not safety.
What I found on the other side, and it’s worse than “unregulated”
Then there’s the part of the market the enforcement wave was actually pointed at, and I’m not going to rank it against the providers above because that would imply it belongs on the same page.
The dangerous route is the vial, full stop. Online retailers and gray-market sellers move “testosterone” as a product, sometimes stamped research-use-only or not-for-human-consumption, sometimes sold outright as a steroid with no medical pretense at all. No clinician. No diagnosis. No prescription. No licensed pharmacy. The structural problem is identical across every one of them, and no headline fixed it. Testosterone is a controlled substance in the US, so buying it this way is illegal, not just unmonitored. That RUO label isn’t a technicality, it’s the legal loophole that lets a seller skip the testing, identity, and purity standards a real medicine has to clear. Nobody checked whether the buyer even has low testosterone. Nobody is tracking his red blood cell count as it climbs, or his prostate, or his fertility. Nobody is accountable for what’s actually inside the vial. Given a hormone that suppresses your own endocrine system and can be contaminated or misdosed, none of that is abstract.
There’s a subtler trap too, one I almost missed on first pass: operations that look medical but aren’t. A thin “consult,” a form reviewed and rubber-stamped in seconds no matter what you answer, no real labs, no follow-up. If anything, the crackdown made these harder to spot, because the ones that survived just learned to dress better. Which is exactly why I built the checklist below.
The seven questions I actually ran on every provider
I couldn’t audit a pharmacy license from my laptop, and neither can you. But I could run the same short set of checks on every provider, checks that the dangerous routes fail structurally, by design, because their whole model depends on skipping these steps.
Does it require real blood work, drawn in the morning, before prescribing anything? A legitimate provider won’t write a script off a questionnaire. Zero blood draw is the single loudest red flag I found anywhere [2].
Does it confirm a low reading more than once? The standard is two separate early-morning measurements [2]. One number is not a diagnosis, it’s a coin flip.
Is a real clinician actually evaluating the case, and still reachable afterward? Not a rubber stamp on a decision already made, but someone who engages with symptoms, looks for a root cause, and sticks around for monitoring.
Where does the hormone physically come from? A licensed pharmacy, including a 503A compounding pharmacy under state and federal oversight, is a different universe from a warehouse shipping vials labeled for research use. Vague sourcing, or a not-for-human-use label, is already your answer.
Does the provider talk about testosterone honestly? It should say plainly that the aging-related use is off-label and unestablished by FDA standards [1], disclose fertility suppression and the need to monitor red blood cells and prostate health, and keep the benefits proportional. The best evidence I found, the Testosterone Trials in older men with confirmed low levels, showed reliable improvement in sexual function, with smaller and less consistent effects on physical function and mood [5]. Anyone promising you a second adolescence is overselling the very trials they’re citing.
Does it hold both halves of the cardiovascular data? The large TRAVERSE trial found testosterone noninferior to placebo for major adverse cardiac events in men with hypogonadism and elevated cardiovascular risk, genuinely reassuring, while also finding higher rates of certain events including pulmonary embolism and atrial fibrillation [4]. A provider that mentions only the reassuring half is telling you something about how carefully they read, or didn’t read, the paper.
Does the relationship keep going after checkout? TRT is long-term therapy. Re-checked labs, monitored blood counts, dose adjustments, a clinician you can actually reach. That’s the line between treatment and a transaction.
I ran all seven on every name in this piece. The legitimate ones didn’t strain against a single question. The dangerous ones failed on question one, because a blood draw they can’t fake is the exact step their entire business model exists to avoid.
What I’d actually do with this
The enforcement wave was a useful event, but for a different reason than most people give it credit for. It didn’t purify anything. It exposed a line that was always sitting there, providers who diagnose and supervise on one side, sellers who just ship on the other. If I were deciding where to get treated, I wouldn’t waste time tracking down which operations got warning letters. I’d just stand on the right side of that line.
That means the diagnosis-first, oversight-first tier: FormBlends leading it, then HealthRX.com right behind on the same footing, with Hone Health, Marek Health, and Defy Medical as legitimate options where the real differences come down to fit rather than safety. It does not mean anything sold under a label that admits it was never meant for a human body, and it does not mean any “consult” designed to wave that vial through. If I thought my own testosterone was low, my first move wouldn’t be picking a product off a page. It would be getting properly diagnosed, real morning blood, confirmed on a second draw, by someone accountable for the answer. Then, and only then, choosing from among the providers who were already doing that before anyone forced them to.
Questions I kept getting asked while researching this
How low does testosterone actually have to go before a doctor treats it?
Most guidelines land around 300 ng/dL on a morning draw, but I found that number alone doesn’t tell the whole story. A doctor worth seeing looks at your symptoms too, runs the test twice on separate days, and checks free testosterone alongside total. Some men feel genuinely unwell at 320, others function fine at 280. The number is a starting point for a conversation, not a verdict handed down.
What’s the standard treatment once someone’s actually diagnosed?
Testosterone replacement therapy, delivered as injections, topical gels, patches, or subcutaneous pellets. Injections tend to be the cheapest and most flexible for dosing. Gels give you steadier daily levels but come with a real transfer risk to partners and kids in the house. Which format makes sense depends on your life, how your levels respond, and what your prescribing doctor can actually keep an eye on.
Does insurance ever cover this?
It’s inconsistent. Most major insurers will cover treatment when you’ve got confirmed low labs and documented symptoms, but expect prior authorization hurdles and restrictions on which formulations they’ll pay for. Gels get denied in favor of generics or injections more often than I expected. Compounding pharmacies, including physician-supervised options like FormBlends, sit outside standard insurance networks entirely, so budget for those costs out of pocket.
Can you actually raise testosterone without a prescription?
If your levels are genuinely low, lifestyle changes alone rarely close that gap, though they help at the margins. Consistent resistance training, better sleep, dropping excess body fat, and managing chronic stress can nudge numbers upward modestly. The supplement aisle marketed as “testosterone boosters” has thin evidence behind it, in my read of the literature. If you’re genuinely low and symptomatic, these habits support treatment, they don’t replace it.
References
- U.S. Food and Drug Administration. “FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use.” March 3, 2015. States that prescription testosterone is approved for men with low testosterone caused by certain medical conditions, that benefit and safety have not been established for low testosterone due to aging, and requires labeling on possible cardiovascular risk. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Mulhall JP, Trost LW, Brannigan RE, et al. “Evaluation and Management of Testosterone Deficiency: AUA Guideline.” J Urol. 2018 Aug;200(2):423-432. PMID 29601923. Sets the diagnostic standard of total testosterone consistently below 300 ng/dL on at least two early-morning measurements, in a man with symptoms. https://pubmed.ncbi.nlm.nih.gov/29601923/
- Bhasin S, Brito JP, Cunningham GR, et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744. PMID 29562364. Recommends diagnosing hypogonadism only in men with both symptoms and unequivocally and consistently low testosterone, and recommends against starting testosterone in men planning fertility in the near term.
- Lincoff AM, Bhasin S, Flevaris P, et al. “Cardiovascular Safety of Testosterone-Replacement Therapy.” N Engl J Med. 2023 Jul 13;389(2):107-117. PMID 37326322. The TRAVERSE trial; testosterone was noninferior to placebo for major adverse cardiac events in men with hypogonadism and cardiovascular risk, with higher rates of certain events including pulmonary embolism and atrial fibrillation.
- Snyder PJ, Bhasin S, Cunningham GR, et al. “Effects of Testosterone Treatment in Older Men.” N Engl J Med. 2016 Feb 18;374(7):611-624. PMID 26886521. The Testosterone Trials in men 65 and older with confirmed low testosterone; testosterone improved sexual function consistently, with smaller and less consistent effects on physical function and vitality.
